title: Associations between cellular immune effector function, iron metabolism, and disease activity in patients with chronic hepatitis C virus infection.
abstract: We studied the associations of macrophage activity, T-helper cell types 1 and 2 (Th-1/Th-2) responses, and iron status in 55 patients with hepatitis C virus (HCV)-related liver disease and 28 control patients with noninfectious liver disease. Serum concentrations of soluble tumor necrosis factor receptor type II (sTNFrec 75), a macrophage activation marker, were higher in cirrhotic than in noncirrhotic patients (P<.001) regardless of their HCV status, whereas levels of neopterin, interleukin (IL)-4 and IL-10 did not differ significantly. In HCV-positive patients, sTNFrec 75 levels and transferrin saturation (TfS) correlated positively with levels of aspartate transaminase (P<.001 for sTNFrec 75 and P=.028 for TfS) and alanine transaminase (P=.003 for sTNFrec 75 and P=.039 for TfS). Increased TfS correlated significantly with both advanced liver disease and a predominant Th-2 pattern in HCV patients. Our data suggest that an association exists between macrophage activation and hepatic dysfunction, and that iron status may affect the clinical course of HCV infection by modulating Th-1/Th-2 responses in vivo.
authors.affiliation: Department of Internal Medicine, University Hospital, Anichstr. 35, A-6020 Innsbruck, Austria. guenter.weiss@uibk.ac.at
authors.forename: G
authors.initials: G
authors.lastname: Weiss
authors.forename: F
authors.initials: F
authors.lastname: Umlauft
authors.forename: M
authors.initials: M
authors.lastname: Urbanek
authors.forename: M
authors.initials: M
authors.lastname: Herold
authors.forename: M
authors.initials: M
authors.lastname: Loyevsky
authors.forename: M
authors.initials: M
authors.lastname: Lovevsky
authors.forename: F
authors.initials: F
authors.lastname: Offner
authors.forename: V R
authors.initials: VR
authors.lastname: Gordeuk
mesh_terms: D015703:Antigens, CD / Q000097:blood; D016022:Case-Control Studies; D018450:Disease Progression; D005293:Ferritins / Q000097:blood; D019698:Hepatitis C, Chronic / Q000276:immunology* / Q000378:metabolism*; D006801:Humans; D007378:Interleukins / Q000097:blood*; D007501:Iron / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008103:Liver Cirrhosis / Q000209:etiology / Q000276:immunology / Q000378:metabolism; D008262:Macrophage Activation; D019798:Neopterin / Q000097:blood; D018124:Receptors, Tumor Necrosis Factor / Q000097:blood; D047889:Receptors, Tumor Necrosis Factor, Type II; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology*; D014168:Transferrin / Q000378:metabolism
chemical_list: D015703:Antigens, CD; D007378:Interleukins; D018124:Receptors, Tumor Necrosis Factor; D047889:Receptors, Tumor Necrosis Factor, Type II; D014168:Transferrin; D019798:Neopterin; D005293:Ferritins; D007501:Iron